Group One Trading’s Repare Therapeutics RPTX Stock Holding History

Group One Trading’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-900	Closed	-$2.34K	–	8582
2025 Q4	$2.34K	Buy	+900	New	+$1.81K	﹤0.01%	7494
2024 Q1	–	Sell	-1,900	Closed	-$13.9K	–	7840
2023 Q4	$13.9K	Sell	1,900 -900	-32%	-$5.04K	﹤0.01%	5991
2023 Q3	$33.8K	Buy	2,800 +1,500	+115%	+$15.5K	﹤0.01%	5448
2023 Q2	$13.8K	Hold	1,300	–	–	﹤0.01%	6215
2023 Q1	$12.8K	Hold	1,300	–	–	﹤0.01%	5791
2022 Q4	$19.1K	Buy	+1,300	New	+$19.4K	﹤0.01%	5626
2022 Q3	–	Sell	-100	Closed	-$1K	–	8135
2022 Q2	$1K	Buy	+100	New	+$1.18K	﹤0.01%	7611

Group One Trading's RPTX Position: Q3 2025 in Review

Group One Trading sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 5,722 shares — an estimated $9.16K sold.

Group One Trading first reported a position in RPTX in Q2 2022 and held it in 10 quarters. The position peaked at $179K in Q2 2022. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.

Group One Trading reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 5,722 Repare Therapeutics shares in Q3 2025, an estimated $9.16K.
Group One Trading first reported a position in Repare Therapeutics in Q2 2022 and held it in 10 quarters.
Group One Trading's Repare Therapeutics position peaked at $179K in Q2 2022.
45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.